Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07480590 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

GLOW: Gender-Affirming Care and Mental Health: A Longitudinal Study On Quality of Life, Work Life, and Healthcare Outcomes

Study acronym: GLOW
StatusRecruiting
PhaseNot specified
Started2025-12-01
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint removed 2 → 1 primary endpoints
See other at-risk trials from Region Skane

Amendment history

2026-09-24
critical
Primary endpoint(s) modified2 to 1 entries
WasChange in Quality of Life, Generic quality of life
NowChange in Quality of Life
2026-05-13
minor
Study Status, Contacts/Locations v2
Study sitesdetails revised at 1 of 1 site
2026-05-06
critical
Study Status, Study Description, Outcome Measures v1
Primary endpoint(s) modified2 entries, revised
WasGender Congruence Life Satisfaction Scale (GCLS), Montgomery-Åsberg Depression Rating Scale (MADRS)
NowChange in Quality of Life, Generic quality of life
Secondary endpoints1 to 12 entries
Substance use Substance use Self-Concept Clarity and Identity Functioning Change in Mental Health Symptoms Change in Mental Health Symptoms Gender Congruence and Life Satisfaction Mortality Work Capacity and Socioeconomic Participation Healthcare Utilization Healthcare Utilization Healthcare Utiliza [...]
Study description+2,160 characters
PURPOSEThe ANDGLOW RESEARCH QUESTIONS Gender dysphoriastudy is a conditionlongitudinal characterizedinvestigation bydesigned distressto orevaluate impairmentthe followingeffects of gender-affirming care on the well-being of individuals diagnosed with gender dysphoria in Sweden. Grounded in an incongruenceinterdisciplinary betweenframework, one'sthe experienced/expressedstudy genderadopts a mixed-methods approach to integrate quantitative registry data and thelongitudinal sex one was assigned at birth (American Psychiatric Association, 2013). It is relatively rare but associatedself-assessments [...]
2026-03-13
minor
Original filing
146 trials monitored
See 5 trials at risk
Gender-Affirming Care and Mental Health (GLOW) investigates the psychological, medical, and social factors that influence the outcomes of gender-affirming care, as well as its impact on mental health, work capacity, and quality of life. Gender dysphoria is defined as the incongruence of a person's experienced gender and sex assigned at birth. In Sweden, the prevalence of gender dysphoria has increased significantly in recent decades. Still there is no consensus on the long-term outcomes ofgender-affirming care. 1. What are the baseline characteristics in individuals seeking gender-affirming care and do any of these predict outcomes of gender-affirmative care?2. Do individuals with gender dysphoria experience improved or reduced quality of life, gender congruence, or functional capacity after gender-affirming care?3. Does gender-affirming care reduce or increase psychiatric symptoms and self-concept clarity?4. What are the effects of gender-affirming care on mortality, work capacity, and healthcare resource utilization as compared to an age and gender matched control group?Data and MethodGLOW targets patients at the Gender Dysphoria Clinic, Region Skåne and Linköping a National Highly Specialized Care unit (NHV). Mixed methods will be used to analyze data from national registries and self-reported assessments.The NHV status ensures standardized high-quality data collection and clinical follow-up, making this project a unique opportunity to evaluate the care given to individuals with gender dysphoria.Societal Relevance and Utility The growing demand for gender-affirming care underscores the need for research to identify the most effective interventions. The results may also help reduce stigma and improve social integration for individuals with genderdysphoria.GLOW is a longitudinal mixed-methods study based at the NHV Gender Dysphoria Clinic in Region Skåne. It includes registry-based, qualitative interviews and repeated self-report measures up to 5 years after baseline assessment. Quantitative analyses will include regression models and Bayesian methods.
Trial Details
NCT Number NCT07480590
Lead Sponsor Region Skane
Conditions Gender Dysphoria, Adult
Enrollment 500 participants
Start Date 2025-12-01
Primary Completion 2030-12-01 (estimated)
Study Completion 2030-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-30